<DOC>
	<DOCNO>NCT02789358</DOCNO>
	<brief_summary>This study aim validate new dosage cryotherapy base time effect pulmonary vein ablation procedures patient paroxysmal atrial fibrillation .</brief_summary>
	<brief_title>A Time-to-effect Based Dosing Strategy Cryoballoon Ablation Patients With Paroxysmal Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<criteria>Patients least 2 documented episode paroxysmal Atrial Fibrillation ( AF ) responder least one antiarrythmic drug Previous leave atrial ablation procedure surgery leave atrium diameter &gt; 50mm presence intracardiac thrombus Left ventricular ejection fraction &lt; 40 % Heart failure class IIIIV Severe valvulopathies Acute coronary syndrome cardiac surgery within previous 3 month enrollment Transient ischemic attack/stroke within previous 6 month enrollment life expectancy le 1 year Any contraindication procedure accord current clinical practice</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cryotherapy</keyword>
</DOC>